Eli Lilly Archives - CFO

CFOs On the Move: Week Ending February 12

CFOs On the Move: Week Ending February 12

Eli Lilly, Pilgrim’s Pride, Belden, Goodwill, Taco John’s, Weee, The Conrad N. Hilton Foundation, Lids, Sema4

By Lauren Muskett | February 12, 2021

Eli Lilly to Buy Cancer Drug Specialists Loxo Oncology

Eli Lilly to Buy Cancer Drug Specialists Loxo Oncology

In the second major pharmaceutical deal of the year, Eli Lilly will pay about $8 billion for Loxo Oncology.

By William Sprouse | January 7, 2019

Lilly’s Elanco Expects IPO to Raise $1.4B

Lilly’s Elanco Expects IPO to Raise $1.4B

The animal health spinoff is the second major industry player to go public, following Zoetis' successful offering.

By Matthew Heller | September 6, 2018

Eli Lilly to Spin Off Animal-Health Business

Corporate Finance

Eli Lilly to Spin Off Animal-Health Business

Eli Lilly reported a quarterly loss of $260 million and announced plans for an IPO of Elanco by the end of 2018.

By William Sprouse | July 24, 2018

CFOs on the Move: Week Ending Oct. 6

CFOs on the Move: Week Ending Oct. 6

Eli Lilly, Mattel, Georgia Power, Pier 1 Imports, Bravo Brio Restaurant Group, Purchasing Power,, White Energy

By Joan Urdang | October 6, 2017

Lilly Veteran Josh Smiley Promoted to CFO

Lilly Veteran Josh Smiley Promoted to CFO

Smiley takes over from Derica Rice amid a cost-cutting push aimed at freeing up cash for Lilly to invest in developing new drugs.

By Matthew Heller | October 2, 2017

Eli Lilly to Trim 3,500 Jobs to Save $500 Million

Eli Lilly to Trim 3,500 Jobs to Save $500 Million

The drugmaker is seeking to become "a leaner, more nimble global organization" as it invests in a new generation of medicines.

By Matthew Heller | September 7, 2017

CFOs on the Move: Week Ending June 3

CFOs on the Move: Week Ending June 3

Uber, Eli Lilly, Occidental Petroleum, Dunkin' Brands, Cloudflare, American Express Business Travel, Neiman Marcus, Proterra, Knoll, Tivity Health

By David McCann | June 2, 2017

New Products Fuel Eli Lilly Q1 Earnings Beat

Financial Performance

New Products Fuel Eli Lilly Q1 Earnings Beat

Drugs such as the diabetes treatment Trulicity "led the company to a strong quarter of volume-driven revenue growth."

By Matthew Heller | April 26, 2017

Lilly Buys Vetmedica Pet Vaccines for $885M

Lilly Buys Vetmedica Pet Vaccines for $885M

The deal will diversify Lilly's Elanco animal medicine business, adding vaccines for rabies and other feline and canine illnesses.

By Matthew Heller | October 5, 2016

The Prescription for Pharma Is Revenue Growth

The Prescription for Pharma Is Revenue Growth

Despite the hullabaloo about health-care reform, investors still reward revenue growth by pharmaceutical companies. But that growth requires organic and acquisitive reinvestment.

By Gregory V. Milano and John R. Cryan | April 4, 2012